Methods: Evidence for this review was obtained from a search of the Cochrane database,
PubMed, guidelines of European Society of Medical Oncology, British society of …

Background: Cancer-related anaemia is one of the main burdens in oncology, although the
available data on its prevalence and treatment options such as blood transfusion are often …

Background: Red blood cell (RBC) transfusion is the standard treatment for anemia in
advanced cancer. Nevertheless, guidelines for managing this condition are still not …

La trasfusión de hemoderivados se utiliza con más frecuencia en pacientes con neoplasias
hematológicas que en pacientes con tumores sólidos, y de forma variable en el caso de …

Introduction Anemia occurs before and after kidney transplantation. Determining the impact
of perioperative transfusion on post-transplant outcomes can help determine best …

Aims Although palliative radiotherapy for gastric cancer may improve some symptoms, it
may also have a negative impact due to its toxicity. We investigated whether symptoms …

Objectives: Restrictive blood transfusion policy has been shown to be effective in managing
anemia. However, treatment of anemia in palliative (PC) and end-of-life (EOL) care remains …

The hemoglobin-to-red cell distribution width ratio (HRR) is a newly proposed composite
parameter for the prognosis evaluation of tumor patients in recent years. Since hemoglobin …

Objective: Describe the use of blood transfusions in the six months before death as an
alternative palliative treatment in patients with an oncological diagnosis in the city of …

Introducció: En els malalts amb càncer avançat en situació pal· liativa són molt freqüents els
símptomes relacionats amb l'anèmia, com l'astènia i la dispnea. Pocs estudis han avaluat …